Get all the latest news on coronavirus and more delivered daily to your inbox.  Sign up here.Biotech Gilead Sciences has given an update on how its drug remdesivir, used to treat Ebola patients, is also being used in the battle against coronavirus.The antiviral, which is awaiting regulatory approval as a coronavirus treatment, is one of a number of drugs in the spotlight as the U.S. scrambles to contain the pandemic. Remdesivir is being used in a number of clinical trials across the globe.“Over the course of the past week, Gilead has been working in consultation with regulatory authorities to establish additional expanded access programs for remdesivir, our investigational medicine for COVID-19,” said Gilead CEO Daniel O’Day, in an open letter sent April 4. “The programs enable hospitals or physicians to apply for emergency use of remdesivir for multiple severely ill patients at a time. These are patients who cannot take part in clinical trials and where the word ‘emergency’ is all too real for them, their families and the health care providers advocating on their behalf.”As America grapples with a growing number of coronavirus cases, demand for experimental drugs such as remdesivir has spiked. The family of Michael Goldsmith, a 34-year-old father of

Continue To Full Article